315 related articles for article (PubMed ID: 15542188)
1. Spontaneously reported adverse reactions after diphtheria-tetanus revaccination at 4-6 years of age--a comparison of two vaccines with different amounts of diphtheria toxoid.
Thierry-Carstensen B; Sjølin Frederiksen M; Andersen PH; Stellfeld M
Vaccine; 2004 Dec; 23(5):668-71. PubMed ID: 15542188
[TBL] [Abstract][Full Text] [Related]
2. How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?
Halperin SA; Sweet L; Baxendale D; Neatby A; Rykers P; Smith B; Zelman M; Maus D; Lavigne P; Decker MD
Pediatr Infect Dis J; 2006 Mar; 25(3):195-200. PubMed ID: 16511379
[TBL] [Abstract][Full Text] [Related]
3. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.
Knuf M; Habermehl P; Faber J; Bock HL; Sänger R; Bogaerts H; Clemens R; Schuind A; du Prel JB; Schmitt HJ
Vaccine; 2006 Jul; 24(27-28):5627-36. PubMed ID: 16740348
[TBL] [Abstract][Full Text] [Related]
4. Adverse events following booster doses of diphtheria-tetanus-inactivated poliovirus and acellular pertussis vaccines for 4-year-old children in The Netherlands.
Bults M; Kemmeren JM; van der Maas NA
Vaccine; 2007 Jul; 25(29):5272-7. PubMed ID: 17573165
[TBL] [Abstract][Full Text] [Related]
5. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.
Langley JM; Predy G; Guasparini R; Law B; Diaz-Mitoma F; Whitstitt P; Tapiero B; Dionne M; Tomovici A; Mills E; Halperin SA
Vaccine; 2007 Jan; 25(6):1121-5. PubMed ID: 17045366
[TBL] [Abstract][Full Text] [Related]
6. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
7. [Effect of leishmanial vaccinations on the dynamics of immunity to diphtheria in conditions of secondary revaccination with adsorbed pertussis-diphtheria-tetanus vaccine].
Serebriakov VA; Karakhodzhaeva S; Dzhumaev MD
Med Parazitol (Mosk); 1972; 41(3):303-7. PubMed ID: 5055832
[No Abstract] [Full Text] [Related]
8. Safety of a fifth dose of diphtheria and tetanus toxoid and acellular pertussis vaccine in children experiencing extensive, local reactions to the fourth dose.
Rennels MB; Black S; Woo EJ; Campbell S; Edwards KM
Pediatr Infect Dis J; 2008 May; 27(5):464-5. PubMed ID: 18398385
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of vaccine safety: comparison of parental reports with routine surveillance and a clinical trial.
Netterlid E; Månsson ME; Håkansson A
Vaccine; 2009 Mar; 27(14):2042-7. PubMed ID: 19428828
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
[TBL] [Abstract][Full Text] [Related]
11. High tetanus and diphtheria antitoxin concentrations in Finnish adults--time for new booster recommendations?
Olander RM; Auranen K; Härkänen T; Leino T
Vaccine; 2009 Aug; 27(39):5295-8. PubMed ID: 19596410
[TBL] [Abstract][Full Text] [Related]
12. Revaccination of adults against diphtheria. II: Combined diphtheria and tetanus revaccination with different doses of diphtheria toxoid 20 years after primary vaccination.
Simonsen O; Klaerke M; Klaerke A; Bloch AV; Hansen BR; Hald N; Hau C; Heron I
Acta Pathol Microbiol Immunol Scand C; 1986 Oct; 94(5):219-25. PubMed ID: 3565028
[TBL] [Abstract][Full Text] [Related]
13. [Adverse reactions to diphtheria-pertussis-tetanus vaccine in the Chilean Immunization Program].
Abarca V K; Cerda L J; Ferreccio R C
Rev Med Chil; 2009 Jan; 137(1):10-7. PubMed ID: 19399316
[TBL] [Abstract][Full Text] [Related]
14. The value of booster vaccinations against diphtheria, tetanus, pertussis and poliomyelitis.
Gabutti G
J Prev Med Hyg; 2008 Mar; 49(1):47-54. PubMed ID: 18792533
[No Abstract] [Full Text] [Related]
15. [Combined vaccine against polio, diphtheria and tetanus. Closing vaccination gaps!].
Banzhoff A; Donner-Banzhoff N; Schwenke C; Girgsdies OE; Jilg W
MMW Fortschr Med; 2000 Nov; 142(48):54. PubMed ID: 11138290
[No Abstract] [Full Text] [Related]
16. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
[TBL] [Abstract][Full Text] [Related]
17. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP
Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985
[TBL] [Abstract][Full Text] [Related]
18. Prospective assessment of the effect of needle length and injection site on the risk of local reactions to the fifth diphtheria-tetanus-acellular pertussis vaccination.
Jackson LA; Starkovich P; Dunstan M; Yu O; Nelson J; Dunn J; Rees T; Zavitkovsky A; Maus D; Froeschle JE; Decker M
Pediatrics; 2008 Mar; 121(3):e646-52. PubMed ID: 18310184
[TBL] [Abstract][Full Text] [Related]
19. Seroprotection against diphtheria and tetanus among Russian and Norwegian teenagers.
Danilova E; Shiryayev A; Kristoffersen EK; Sjursen H
APMIS; 2006 Jun; 114(6):453-7. PubMed ID: 16856968
[TBL] [Abstract][Full Text] [Related]
20. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules.
Pichichero ME; Casey JR; Francis AB; Marsocci SM; Murphy M; Hoeger W; Cleary C
Clin Pediatr (Phila); 2006 Sep; 45(7):613-20. PubMed ID: 16928838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
